The increasing prevalence of chronic and infectious diseases is propelling the growth for the global pyrogen testing market says fortune business insights in a report titled “Pyrogen Testing Market Size, Share and Global Trend By Test (Oncology Monocyte Activation Test (MAT), Limulus Amebocyte Lysate (LAL), Rabbit Pyrogen Test Recombinant Factor C Assay (RFC), In Vitro Pyrogen Test), By Product (Instruments, Consumables), By End User (Food & Beverage Companies, Medical Devices Companies, Pharmaceuticals Companies, Biotechnology Companies & Others), and Geography Forecast Till 2026”.
Get Sample PDF [email protected]
Some of the Main Key Players Covered in the Pyrogen Testing Market Report:
- Charles River
- Associates of Cape Cod, Inc.
- Hyglos GmbH
- Ellab A/S
- Merck KGaA
- Wako USA
- WuXi AppTec.
Merck Partners with Solvias for Advanced Pyrogen Recognition Kit
Merck, a leading technology company announced its partnership with Solvias, the world leader in contract research, development and manufacturing of (CRO/CDMO). The collaboration unveiled PyroMAT™ System, a new Monocyte Activation Test kit for pyrogen detection. The new kit is predicted to witness demand owing to the first cell line based Monocyte Activation Test kit available in the market which can identify numerous kind of pyrogens in pharmaceutical raw materials and products.
Browse Complete Report Details @
This factor is expected to drive and enable growth for the global pyrogen testing market. The contamination caused due to the presence of pyrogen in biotherapeutics, medical devices and pharmaceutical products, is also a factor fueling demand for pyrogen testing and creating opportunities for companies to launch new products. For instance, Wickham Laboratories announced the Monocyte Activation Test, a new vitro test method, for the assessment of pyrogenicity of pharmaceutical products and medical devices.
North America to Dominate the Global Pyrogen Testing Market
Geographically, the global pyrogen testing market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa. North America is presently leading the market as it witnesses an increasing number of cases of chronic and infectious diseases and a high presence of pharmaceutical and biotechnology companies.
North America is predicted to dominate the global market during the forecast period owing to the strict regulatory framework, improvements in R&D activities and well-developed health care infrastructure.
The Asia Pacific market is projected to rise at a significant rate during the forecast period owing to the fewer stringent policies by the government for the development of drugs in the region.
Rising demand for pyrogen products in the pharmaceuticals and biotechnology industries is enabling growth in the global pyrogen testing market.
R&D Activities to Speed Up Market Growth
Pyrogen is a substance, generally biotic in nature and causes fever. Pyrogen is categorized into two types exogenous pyrogen and endogenous pyrogen. Endogenous pyrogen remains unconstrained due to phagocytosis, in which bacteria are absorbed by phagocytes, a distinct cell, which defends the body from harmful means.
The discharged endogenous pyrogen ventures upon the brain’s hypothalamus thus increasing the body temperature. Growing demand for pyrogen testing products in the biotechnology and pharmaceutical industry along with increasing investments in R&D activities for pyrogen testing kits are some of the factors anticipated to boost the growth of the global pyrogen testing market.
More Trending Topics from Fortune Business Insights: